Engineers Gate Manager’s Ginkgo Bioworks DNA Stock Holding History

Engineers Gate Manager’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44,574	Closed	-$273K	–	2320
2026 Q1	$273K	Buy	44,574 +13,466	+43%	+$112K	﹤0.01%	1753
2025 Q4	$259K	Buy	+31,108	New	+$335K	﹤0.01%	1707
2025 Q3	–	Sell	-39,263	Closed	-$442K	–	2252
2025 Q2	$442K	Buy	39,263 +11,995	+44%	+$92.9K	0.01%	1538
2025 Q1	$155K	Sell	27,268 -25,314	-48%	-$258K	﹤0.01%	1941
2024 Q4	$516K	Buy	+52,582	New	+$451K	0.01%	1402
2024 Q3	–	Sell	-268	Closed	-$3.59K	–	2181
2024 Q2	$3.59K	Sell	268 -2,697	-91%	-$80.5K	﹤0.01%	1876
2024 Q1	$138K	Buy	+2,965	New	+$153K	﹤0.01%	1702
2023 Q3	–	Sell	-978	Closed	-$72.8K	–	1856
2023 Q2	$72.8K	Buy	+978	New	+$57.9K	﹤0.01%	1600
2022 Q3	–	Sell	-266	Closed	-$25K	–	1720
2022 Q2	$25K	Buy	+266	New	+$32.4K	﹤0.01%	1814
2022 Q1	–	Sell	-1,010	Closed	-$336K	–	1950
2021 Q4	$336K	Buy	+1,010	New	+$480K	0.02%	1324

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Engineers Gate Manager's DNA Position: Q2 2026 in Review

Engineers Gate Manager sold out of Ginkgo Bioworks (DNA) in Q2 2026, closing a stake of 44,574 shares — an estimated $273K sold.

Engineers Gate Manager first reported a position in DNA in Q4 2021 and held it in 10 quarters. The position peaked at $516K in Q4 2024. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Engineers Gate Manager reported no remaining Ginkgo Bioworks position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 44,574 Ginkgo Bioworks shares in Q2 2026, an estimated $273K.
Engineers Gate Manager first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 10 quarters.
Engineers Gate Manager's Ginkgo Bioworks position peaked at $516K in Q4 2024.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.